Ladostigil
| TV-3326 | |
|---|---|
 |
| Salts [] | |
|---|---|
| Ladostigil hemitartrate | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 272.34 g/mol [1] |
| Predicted LogP | 2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H20N2O2 [1] |
| IUPAC name | [(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate [1] |
| SMILES | CCN(C)C(=O)OC1=CC2=C(CC[C@H]2NCC#C)C=C1 [1] |
| InChI | InChI=1S/C16H20N2O2/c1-4-10-17-15-9-7-12-6-8-13(11-14(12)15)20-16(19)18(3)5-2/h1,6,8,11,15,17H,5,7,9-10H2,2-3H3/t15-/m1/s1 [1] |
| InChIKey | LHXOCOHMBFOVJS-OAHLLOKOSA-N [1] |
Ladostigil (also known as Ladostigilo, Tv-3326 free base, Dtxsid101045854, ladostigilum, Dtxcid301527785, Ladostigil free base, TV3326, R-CPAI, 3-(Prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl ethyl(methyl)carbamate or (N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate) is a
Chemistry
Salts []
Ladostigil is typically found in the form of its hemitartrate salt.
Stereochemistry []
Ladostigil is a absolute mixture.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 208907, Ladostigil. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/208907
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ladostigil. UNII: SW3H1USR4Q. Global Substance Registration System. Accessed May 8, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/SW3H1USR4Q